论文部分内容阅读
卵巢肿瘤是女性生殖器常见恶性肿瘤之一,死亡率居妇科肿瘤首位,因缺乏早期诊断手段,70%以上的卵巢癌确诊时都已处于晚期,故预后极差。因此,卵巢恶性肿瘤是妇产科临床诊断及治疗中的难点。文献报道,微小RNA(microRNA,miRNA)在多种肿瘤中均有表达,并发挥重要的生物作用,并且miRNA还参与卵巢癌的发生、发展、耐药等过程,已成为当前研究的重点。miRNA由长度约22-25nt的非
Ovarian cancer is one of the most common malignant tumors in female genital mutilation. The mortality rate ranks the first among gynecological cancers. Because of the lack of early diagnosis, more than 70% of ovarian cancers have been diagnosed late, so the prognosis is very poor. Therefore, ovarian cancer is the clinical diagnosis and treatment of gynecological difficulties. It has been reported in the literature that microRNAs (miRNAs) are expressed in many tumors and play important biological roles. MiRNAs are also involved in the development, development and drug resistance of ovarian cancer, and have become the focus of current research. The miRNA consists of non-specific lengths of about 22-25 nt